{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:42:12Z","timestamp":1789656132711,"version":"4.0.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s10554-020-01923-4","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T15:47:41Z","timestamp":1593618461000},"page":"2199-2207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Reproducibility of cardiac magnetic resonance imaging in patients referred for the assessment of cardiac sarcoidosis; implications for clinical practice"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8575-1556","authenticated-orcid":false,"given":"Daniel","family":"Juneau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo B.","family":"Nery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o R.","family":"In\u00e1cio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob S. B.","family":"Beanlands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"deKemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab M.","family":"Alhajari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart","family":"Spence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Medor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Birnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,1]]},"reference":[{"key":"1923_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","volume":"58","author":"KJ Silverman","year":"1978","unstructured":"Silverman KJ, Hutchins GM, Bulkley BH (1978) Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58:1204\u20131211","journal-title":"Circulation"},{"key":"1923_CR2","first-page":"372","volume":"43","author":"K Iwai","year":"1993","unstructured":"Iwai K, Tachibana T, Takemura T, Matsui Y, Kitaichi M, Kawabata Y (1993) Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn 43:372\u2013376","journal-title":"Acta Pathol Jpn"},{"key":"1923_CR3","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/jce.12401","volume":"25","author":"PB Nery","year":"2014","unstructured":"Nery PB, Beanlands RS, Nair GM, Green M, Yang J, McArdle BA et al (2014) Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults. J Cardiovasc Electrophysiol 25:875\u2013881","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1923_CR4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/pace.12277","volume":"37","author":"PB Nery","year":"2014","unstructured":"Nery PB, Mc Ardle BA, Redpath CJ, Leung E, Lemery R, Dekemp R et al (2014) Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia. Pacing Clin Electrophysiol PACE 37:364\u2013374","journal-title":"Pacing Clin Electrophysiol PACE"},{"key":"1923_CR5","doi-asserted-by":"publisher","first-page":"e006145","DOI":"10.1161\/CIRCEP.117.006145","volume":"11","author":"H-K Nordenswan","year":"2018","unstructured":"Nordenswan H-K, Lehtonen J, Ekstr\u00f6m K, Kandolin R, Simonen P, M\u00e4yr\u00e4np\u00e4\u00e4 M et al (2018) Outcome of cardiac sarcoidosis presenting with high-grade atrioventricular block. Circ Arrhythm Electrophysiol 11:e006145","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1923_CR6","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","volume":"11","author":"DH Birnie","year":"2014","unstructured":"Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS et al (2014) HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm Off J Heart Rhythm Soc 11:1305\u20131323","journal-title":"Heart Rhythm Off J Heart Rhythm Soc"},{"key":"1923_CR7","first-page":"1324","volume":"58","author":"H Ohira","year":"2017","unstructured":"Ohira H, Ardle BM, deKemp RA, Nery P, Juneau D, Renaud JM et al (2017) Inter- and intraobserver agreement of (18)F-FDG PET\/CT image interpretation in patients referred for assessment of cardiac sarcoidosis. J Nucl Med Off Publ Soc Nucl Med 58:1324\u20131329","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"1923_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.17996\/anc.17-00042","volume":"3","author":"F Terasaki","year":"2017","unstructured":"Terasaki F, Yoshinaga K (2017) New guidelines for diagnosis of cardiac sarcoidosis in Japan. Ann Nucl Cardiol 3:42\u201345","journal-title":"Ann Nucl Cardiol"},{"key":"1923_CR9","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.jcmg.2016.02.031","volume":"9","author":"Z Weng","year":"2016","unstructured":"Weng Z, Yao J, Chan RH, He J, Yang X, Zhou Y et al (2016) Prognostic value of LGE-CMR in HCM: a meta-analysis. JACC Cardiovasc Imaging 9:1392\u20131402","journal-title":"JACC Cardiovasc Imaging"},{"key":"1923_CR10","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1161\/CIRCULATIONAHA.105.606509","volume":"114","author":"H Mahrholdt","year":"2006","unstructured":"Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G et al (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114:1581\u20131590","journal-title":"Circulation"},{"key":"1923_CR11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1161\/CIRCIMAGING.113.001768","volume":"7","author":"F Almehmadi","year":"2014","unstructured":"Almehmadi F, Joncas SX, Nevis I, Zahrani M, Bokhari M, Stirrat J et al (2014) Prevalence of myocardial fibrosis patterns in patients with systolic dysfunction: prognostic significance for the prediction of sudden cardiac arrest or appropriate implantable cardiac defibrillator therapy. Circ Cardiovasc Imaging 7:593\u2013600","journal-title":"Circ Cardiovasc Imaging"},{"key":"1923_CR12","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","volume":"120","author":"MR Patel","year":"2009","unstructured":"Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA et al (2009) Detection of myocardial damage in patients with sarcoidosis. Circulation 120:1969\u20131977","journal-title":"Circulation"},{"key":"1923_CR13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","volume":"68","author":"DH Birnie","year":"2016","unstructured":"Birnie DH, Nery PB, Ha AC, Beanlands RSB (2016) Cardiac sarcoidosis. J Am Coll Cardiol 68:411\u2013421","journal-title":"J Am Coll Cardiol"},{"key":"1923_CR14","doi-asserted-by":"crossref","first-page":"e005001","DOI":"10.1161\/CIRCIMAGING.116.005001","volume":"9","author":"E Hulten","year":"2016","unstructured":"Hulten E, Agarwal V, Cahill M, Cole G, Vita T, Parrish S et al (2016) Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: a systematic review and meta-analysis. Circ Cardiovasc Imaging 9:e005001","journal-title":"Circ Cardiovasc Imaging"},{"key":"1923_CR15","doi-asserted-by":"publisher","first-page":"e006685","DOI":"10.1161\/CIRCEP.118.006685","volume":"11","author":"D Birnie","year":"2018","unstructured":"Birnie D, Ha A, Kron J (2018) Which patients with cardiac sarcoidosis should receive implantable cardioverter-defibrillators. Circ Arrhythm Electrophysiol 11:e006685","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1923_CR16","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1016\/j.hrthm.2017.10.036","volume":"15","author":"SM Al-Khatib","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB et al (2018) 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm 15:e73\u2013189","journal-title":"Heart Rhythm"},{"key":"1923_CR17","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.ijcard.2016.07.233","volume":"222","author":"L Agoston-Coldea","year":"2016","unstructured":"Agoston-Coldea L, Kouaho S, Sacre K, Dossier A, Escoubet B, Chillon S et al (2016) High mass (>18g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis. Int J Cardiol 222:950\u2013956","journal-title":"Int J Cardiol"},{"key":"1923_CR18","first-page":"1165","volume":"100","author":"T Ise","year":"2014","unstructured":"Ise T, Hasegawa T, Morita Y, Yamada N, Funada A, Takahama H et al (2014) Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis. Heart Br Card Soc 100:1165\u20131172","journal-title":"Heart Br Card Soc"},{"key":"1923_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/ehf2.12201","volume":"5","author":"J-P Smedema","year":"2018","unstructured":"Smedema J-P, van Geuns R-J, Ector J, Heidbuchel H, Ainslie G, Crijns HJGM (2018) Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis. ESC Heart Fail 5:157\u2013171","journal-title":"ESC Heart Fail"},{"key":"1923_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jcmg.2010.11.015","volume":"4","author":"AS Flett","year":"2011","unstructured":"Flett AS, Hasleton J, Cook C, Hausenloy D, Quarta G, Ariti C et al (2011) Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging 4:150\u2013156","journal-title":"JACC Cardiovasc Imaging"},{"key":"1923_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12968-014-0085-x","volume":"16","author":"Y Mikami","year":"2014","unstructured":"Mikami Y, Kolman L, Joncas SX, Stirrat J, Scholl D, Rajchl M et al (2014) Accuracy and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 16:85","journal-title":"J Cardiovasc Magn Reson"},{"key":"1923_CR22","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1046\/j.1540-8167.2004.03429.x","volume":"15","author":"C Bomma","year":"2004","unstructured":"Bomma C, Rutberg J, Tandri H, Nasir K, Roguin A, Tichnell C et al (2004) Misdiagnosis of arrhythmogenic right ventricular dysplasia\/cardiomyopathy. J Cardiovasc Electrophysiol 15:300\u2013306","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1923_CR23","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.108.840827","volume":"121","author":"FI Marcus","year":"2010","unstructured":"Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA et al (2010) Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia. Circulation 121:1533\u20131541","journal-title":"Circulation"},{"key":"1923_CR24","doi-asserted-by":"publisher","first-page":"e007030","DOI":"10.1161\/CIRCIMAGING.117.007030","volume":"11","author":"T Vita","year":"2018","unstructured":"Vita T, Okada DR, Veillet-Chowdhury M, Bravo PE, Mullins E, Hulten E et al (2018) Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis CLINICAL PERSPECTIVE. Circ Cardiovasc Imaging 11:e007030","journal-title":"Circ Cardiovasc Imaging"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-020-01923-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-020-01923-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-020-01923-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T16:24:17Z","timestamp":1667233457000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-020-01923-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["1923"],"URL":"https:\/\/doi.org\/10.1007\/s10554-020-01923-4","relation":{},"ISSN":["1569-5794","1573-0743"],"issn-type":[{"value":"1569-5794","type":"print"},{"value":"1573-0743","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,1]]},"assertion":[{"value":"11 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"RSB is consultant for- and has received grant funding from GE Healthcare, Lantheus Medical Imaging, and Jubilant DraxImage. DJ is a consultant for AbbVie and Advanced Accelerator Applications. GD provides consultancy support to Artrya Inc. RDK is consultant for- and received grant funding from Jubilant DraxImage, receives royalties from Rubidium-82 generator technologies licensed to Jubilant DraxImage, and from sales of FlowQuant software. All other authors have no relevant conflict of interest or disclosure.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest:"}}]}}